| John E Vance, DO | |
|
8235 N Holly Rd, Suite 1, Grand Blanc, MI 48439-2441 | |
| (810) 694-9700 | |
| (810) 694-9940 |
| Full Name | John E Vance |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 29 Years |
| Location | 8235 N Holly Rd, Grand Blanc, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427074772 | NPI | - | NPPES |
| 0987785 | Other | MI | GENESEE HEALTH PLAN |
| 0989830003 | Other | MI | BLUE CROSS MEDICARE ADVAN |
| 5250193 | Other | MI | BLUE CROSS |
| 5250193 | Other | MI | BLUE CARE NETWORK |
| 114190217 | Medicaid | MI | |
| 7292237 | Other | MI | AETNA |
| C7107 | Other | MI | MCARE |
| 1006245 | Other | MI | MCLAREN HEALTH PLAN |
| 127401 | Other | MI | PREFERRED CHOICE |
| 382626202 | Other | MI | CARE CHOICES |
| 020046189 | Other | MI | PALMETTO GBA - RR MEDICAR |
| H13883 | Other | MI | HAP |
| 0987785 | Other | MI | HEALTH PLUS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 5101012733 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesys Regional Medical Center - Health Park | Grand blanc, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Surgical Associates, Plc | 6406839471 | 4 |
News Archive
Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.
Achilles tendon disorders are common and often misdiagnosed, with about 25 percent of ruptures missed during initial examination, but the prognosis is favorable for the vast majority of patients, according to researchers from Rowan University School of Osteopathic Medicine and the Rothman Institute of Jefferson Medical College.
In patients with a complete blockage in the heart's arteries that persists over time, treatment with medications alone was found to be equal to percutaneous coronary intervention (PCI), a procedure to open blocked arteries, in terms of major adverse events over three years, according to a study presented at the American College of Cardiology's 66th Annual Scientific Session.
NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.
› Verified 1 days ago
| Entity Name | Ascension Genesys Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528283033 PECOS PAC ID: 2062323033 Enrollment ID: O20031208000842 |
News Archive
Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.
Achilles tendon disorders are common and often misdiagnosed, with about 25 percent of ruptures missed during initial examination, but the prognosis is favorable for the vast majority of patients, according to researchers from Rowan University School of Osteopathic Medicine and the Rothman Institute of Jefferson Medical College.
In patients with a complete blockage in the heart's arteries that persists over time, treatment with medications alone was found to be equal to percutaneous coronary intervention (PCI), a procedure to open blocked arteries, in terms of major adverse events over three years, according to a study presented at the American College of Cardiology's 66th Annual Scientific Session.
NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.
› Verified 1 days ago
| Entity Name | Surgical Associates, Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427197490 PECOS PAC ID: 6406839471 Enrollment ID: O20040610000898 |
News Archive
Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.
Achilles tendon disorders are common and often misdiagnosed, with about 25 percent of ruptures missed during initial examination, but the prognosis is favorable for the vast majority of patients, according to researchers from Rowan University School of Osteopathic Medicine and the Rothman Institute of Jefferson Medical College.
In patients with a complete blockage in the heart's arteries that persists over time, treatment with medications alone was found to be equal to percutaneous coronary intervention (PCI), a procedure to open blocked arteries, in terms of major adverse events over three years, according to a study presented at the American College of Cardiology's 66th Annual Scientific Session.
NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John E Vance, DO 8235 N Holly Rd, Suite 1, Grand Blanc, MI 48439-2441 Ph: (810) 694-9700 | John E Vance, DO 8235 N Holly Rd, Suite 1, Grand Blanc, MI 48439-2441 Ph: (810) 694-9700 |
News Archive
Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.
A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.
Achilles tendon disorders are common and often misdiagnosed, with about 25 percent of ruptures missed during initial examination, but the prognosis is favorable for the vast majority of patients, according to researchers from Rowan University School of Osteopathic Medicine and the Rothman Institute of Jefferson Medical College.
In patients with a complete blockage in the heart's arteries that persists over time, treatment with medications alone was found to be equal to percutaneous coronary intervention (PCI), a procedure to open blocked arteries, in terms of major adverse events over three years, according to a study presented at the American College of Cardiology's 66th Annual Scientific Session.
NanoSmart™ Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology.
› Verified 1 days ago
Joseph Allen Kingsbury, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1620 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-7190 Fax: 810-606-7186 | |
Dr. Holland Taylor Korbitz, DO Surgery Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5981 | |
Dr. Ashley Marie Richardson, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-5000 | |
Andrea Jo Goethals, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 8235 Holly Rd, Suite 1, Grand Blanc, MI 48439 Phone: 810-694-9700 Fax: 810-694-9940 | |
Dr. Brian Scott Shapiro, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9463 Holly Rd, Suite 102, Grand Blanc, MI 48439 Phone: 810-579-2600 Fax: 810-579-2601 | |
Sara N Nesheiwat, DO Surgery Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 810-606-7714 | |
Dr. Hutton White, MD Surgery Medicare: Medicare Enrolled Practice Location: 1 Genesys Pkwy, Grand Blanc, MI 48439 Phone: 270-839-0743 |